Health and Healthcare

Alexion Pharmaceuticals, Inc. : ALXN

All ALXN Articles

307 Articles

Lee Jackson | Jul 28, 2017 at 10:20 AM EDT

Analyst Has Top Biotech Stocks to Buy as Sector Stays Red Hot

After a wretched 2016, when many of the top biotech companies were hit hard by campaign rhetoric, the industry has…

Chris Lange | Jul 26, 2017 at 9:35 AM EDT

Short Sellers Run for Cover From Major Biotech Stocks

The July 14 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Jul 13, 2017 at 9:40 AM EDT

Short Sellers Hike Bets in Major Biotechs

The June 30 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Jun 27, 2017 at 8:50 AM EDT

Major Biotech Short Interest Surges

The June 15 short interest data have been compared with the previous report, and short interest in most of the…

Jon C. Ogg | Jun 20, 2017 at 10:45 AM EDT

Large Insider Buying at Alexion Raises Investors’ Eyebrows

Most of the large biotech outfits in America have gone into a limbo mode. Alexion Pharmaceuticals fits that bill despite…

Chris Lange | Jun 14, 2017 at 4:02 PM EDT

Wednesday’s Biggest Winners and Losers in the S&P 500

Wednesday saw a mixed reaction in the broad markets with the S&P 500 and Nasdaq largely down offsetting Tuesdays gains,…

Chris Lange | Jun 14, 2017 at 9:15 AM EDT

Alexion Pharmaceuticals Adds New CFO From Biogen

Shares of Alexion Pharmaceuticals saw a handy gain early on Wednesday after the company announced that there would be changes…

Chris Lange | Jun 12, 2017 at 9:40 AM EDT

Short Interest Surges in Major Biotechs

The May 31 short interest data have been compared with the previous report, and short interest in most of the…

Jon C. Ogg | Jun 11, 2017 at 10:13 AM EDT

4 Top Analyst Stock Picks Predicted to Rise 50% to 100%

These are four of the top pick stocks from Credit Suisse with 50% to 100% upside targets.

Paul Ausick | May 26, 2017 at 4:04 PM EDT

Avon, Fitbit Plunge into Friday’s 52-Week Low Club

Avon, Noble Corp., Fitbit, and Alexion Pharma posted new 52-week lows Friday.

Chris Lange | May 25, 2017 at 9:50 AM EDT

Short Sellers Raise the Stakes in Major Biotechs

The May 15 short interest data have been compared with the previous report, and moves in the selected biotech stocks…

Jon C. Ogg | May 25, 2017 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: Akamai, Alexion, Altria, Chipotle, MEI Pharma, Netflix, PayPal and More

The top analyst upgrades, downgrades and other research calls from Thursday include Akamai Technologies, Alexion Pharmaceuticals, Altria, Chipotle Mexican Grill,…

Paul Ausick | May 24, 2017 at 4:07 PM EDT

Chico’s FAS, Southwestern Energy Drop into Wednesday’s 52-Week Low Club

Chico's FAS, Southwestern Energy, Teva, and Alexion all posted new 52-week lows Wednesday.

Paul Ausick | May 23, 2017 at 4:04 PM EDT

Alexion, Teva Plunge into Tuesday’s 52-Week Low Club

Alexion, Teva, DSW, and Cerus all posted new 52-week lows on Tuesday.

Chris Lange | May 10, 2017 at 10:40 AM EDT

Major Biotech Short Interest Remains Mixed

The April 28 short interest data have been compared with the previous report, and moves in the selected biotech stocks…

1 … 8 9 10 11 12 … 21

Alexion Pharmaceuticals, Inc. : ALXN

All ALXN Articles

Analyst Has Top Biotech Stocks to Buy as Sector Stays Red Hot

Short Sellers Run for Cover From Major Biotech Stocks

Short Sellers Hike Bets in Major Biotechs

Major Biotech Short Interest Surges

Large Insider Buying at Alexion Raises Investors’ Eyebrows

Wednesday’s Biggest Winners and Losers in the S&P 500

Alexion Pharmaceuticals Adds New CFO From Biogen

Short Interest Surges in Major Biotechs

4 Top Analyst Stock Picks Predicted to Rise 50% to 100%

Avon, Fitbit Plunge into Friday’s 52-Week Low Club

Short Sellers Raise the Stakes in Major Biotechs

Top Analyst Upgrades and Downgrades: Akamai, Alexion, Altria, Chipotle, MEI Pharma, Netflix, PayPal and More

Chico’s FAS, Southwestern Energy Drop into Wednesday’s 52-Week Low Club

Alexion, Teva Plunge into Tuesday’s 52-Week Low Club

Major Biotech Short Interest Remains Mixed

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Alexion Pharmaceuticals, Inc. : ALXN

All ALXN Articles

Analyst Has Top Biotech Stocks to Buy as Sector Stays Red Hot

Short Sellers Run for Cover From Major Biotech Stocks

Short Sellers Hike Bets in Major Biotechs

Major Biotech Short Interest Surges

Large Insider Buying at Alexion Raises Investors’ Eyebrows

Wednesday’s Biggest Winners and Losers in the S&P 500

Alexion Pharmaceuticals Adds New CFO From Biogen

Short Interest Surges in Major Biotechs

4 Top Analyst Stock Picks Predicted to Rise 50% to 100%

Avon, Fitbit Plunge into Friday’s 52-Week Low Club

Short Sellers Raise the Stakes in Major Biotechs

Top Analyst Upgrades and Downgrades: Akamai, Alexion, Altria, Chipotle, MEI Pharma, Netflix, PayPal and More

Chico’s FAS, Southwestern Energy Drop into Wednesday’s 52-Week Low Club

Alexion, Teva Plunge into Tuesday’s 52-Week Low Club

Major Biotech Short Interest Remains Mixed

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%